# GLP-1 receptor agonists: Science

Source page: https://www.materialinsights.org/technologies/glp1_agonists/tech-science/

#### Principles

The science it rests on, with why each principle matters to it
 Relies on

- [Hormones](https://www.materialinsights.org/science/hormones/) GLP-1 is a gut hormone carried in the blood, and the drugs copy its message to the pancreas and brain ^[1].
- [Receptor theory of drug action](https://www.materialinsights.org/science/receptor_theory/) The drugs work by fitting the GLP-1 receptor on target cells, so a changed peptide can give the same signal for longer.
- [The genetic code](https://www.materialinsights.org/science/genetic_code/) GLP-1 was found by reading the glucagon gene, whose code predicted a precursor protein holding further peptides ^[1].

as of 2026-11-11

#### Discoveries

The discoveries that made it possible: when, by whom and what was found

| Year | Who | What |
|---|---|---|
| 1982 | Joel Habener | The fish glucagon gene encodes a precursor that holds a second, unknown peptide ^[1] |
| 1986 | Svetlana Mojsov, Joel Habener and colleagues | The short form GLP-1 (7 to 37) exists in nature, in the intestine ^[1] |
| 1987 | Svetlana Mojsov, Gordon Weir and Joel Habener | Tiny amounts of GLP-1 (7 to 37) make the pancreas release insulin ^[1] |
| 1992 | John Eng | Exendin-4, a GLP-1 mimic in Gila monster venom ^[2] |

as of 2026-11-11

#### The science explained

The science behind it explained for a curious reader

Think of the GLP-1 receptor as a lock on the surface of cells in the pancreas and brain. After a meal the gut sends out a key, the hormone GLP-1, through the blood. When the key turns the lock, the pancreas releases insulin if blood sugar is high, and the brain senses fullness ^[1]. The trouble is that the natural key dissolves within minutes ^[1]. Medicines are copies of the key with small changes: they still turn the lock, but enzymes cannot easily break them, and some cling to blood proteins so they are cleared slowly. Making the key last longer turned a short signal after each meal into a steady one, which is what controls blood sugar and appetite over weeks.

as of 2026-11-11

#### Sources

1. [GLP-1-based therapy for obesity](https://laskerfoundation.org/winners/glp-1-based-therapy-for-obesity/) Lasker Foundation (2024 Lasker~DeBakey Clinical Medical Research Award), 2024
2. [Dr. John Eng to Receive Golden Goose Award](https://www.sciencecoalition.org/2013/07/30/dr-john-eng-to-receive-golden-goose-award/) The Science Coalition, 2013

## Other sections

- [Summary](https://www.materialinsights.org/technologies/glp1_agonists/index.md)
- [Overview](https://www.materialinsights.org/technologies/glp1_agonists/tech-overview/index.md)
- [Evolution](https://www.materialinsights.org/technologies/glp1_agonists/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/glp1_agonists/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/glp1_agonists/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/glp1_agonists/tech-industries/index.md)
